- Stocks Telegraph
- Posts
- π Stocks Fell Again... But This Detail Changes Everything
π Stocks Fell Again... But This Detail Changes Everything

The Newsheater Daily Mid-Day Newsletter is powered by Stocks Telegraph
U.S. stocks extended losses on Thursday as a sharp spike in oil prices, driven by escalating strikes on key Middle East energy facilities, intensified inflation concerns on Wall Street. The Dow Jones Industrial Average fell 0.5% to its lowest close of the year, while the S&P 500 and Nasdaq Composite dropped 0.5% and 0.6%, respectively.
Brent crude surged as much as 10% before settling near $112 per barrel amid rising tensions between Iran and Israel, while West Texas Intermediate lagged around $96, widening the price gap between the two benchmarks.
Investors were already cautious following higher inflation forecasts from the Federal Reserve and reduced expectations for rate cuts, especially after hawkish remarks from Chair Jerome Powell. Meanwhile, jobless claims fell to 205,000, with further economic data awaited.
Med-X is gearing up for a Nasdaq listing (MXRX)-but the real opportunity is now, before Wall Street takes notice. Their all-natural Nature-Cide pesticides are already on shelves at e-commerce giants like Walmart, Amazon, and Kroger, with $6.4M in revenue and expansion into 41+ markets.
As climate, regulation, and consumer demand drive a $17B industry toward natural solutions, Med-X is positioned to lead. Shares are just $4.00 through a limited Reg A+ offering.
Don't wait for the headlines-[Review the Med-X investment opportunity today]
Disclosures: This is a paid advertisement for Med-X's Regulation A+ Offering. Please read the offering circular at invest.medx-rx.com.
Sponsored
Top Movers: Under $10
Duluth Holdings Inc (DLTH) is up 34.97% today to trade at the current level of $2.97. This comes after the company announced fourth-quarter and fiscal 2025 financial results.
China Natural Resources Inc (CHNR) zoomed 28.79% in todayβs trade to $4.25 after announcing non-binding letter of intent to acquire a majority stake in HooRii Technology, marking strategic shift to Physical AI.
In current trading, Mobix Labs Inc (MOBX) stock is at $0.66 after announcing that it has been selected by a major munitions manufacturer for a smart munitions feasibility program focused on anti-drone applications.
Serina Therapeutics Inc (SER) rose 73.05% in the early hours of today's trading to move at $2.21 after announcing that it has entered into definitive agreements for the private placement of common stock and pre-funded warrants raising $15 million in gross proceeds.
In the current trading session, SUNation Energy Inc (SUNE) jumped 35.24% to $1.95 over a previous close of $1.44 after reporting fourth quarter and full year 2025 financial results.
Med-X (preparing for a Nasdaq listing under ticker MXRX) is shaking up pest control with its eco-friendly Nature-Cide products-already trusted by pros and sold through e-commerce giants like Amazon, Walmart, Kroger, and more. With $6.4M in revenue and expansion into 41+ global markets, Med-X is riding the wave of climate, regulatory, and consumer demand for safer, plant-based solutions.
Shares are currently available at $4.00 through a Regulation A+ offering.
[Review the Med-X investment opportunity now]
Disclosures: This is a paid advertisement for Med-X's Regulation A+ Offering. Please read the offering circular at invest.medx-rx.com.
Sponsored
Ex-Dividend Stocks
Allient Inc (ALNT) is about to trade ex-dividend tomorrow, meaning that investors who buy the stock after tomorrow will not be eligible for the next dividend payment. The company's next dividend payment will be $0.03 per share. It has fixed March 20 as the record date for the same and will pay the actual dividend on April 03. Last year, the company distributed a total of $0.12 to its shareholders. Based on the last year's worth of payments, ALNT has a trailing yield of 0.20% on the current stock price of $60.9.
Another stock that is shelling out dividends tomorrow is Academy Sports and Outdoors Inc (ASO), having a market capitalization of $3.31B. It will pay a dividend of $0.15 per share, the payment date of which is April 10. Currently, the stock is trading at a trailing dividend yield of 1.01%.
Shares of Fidus Investment Corp (FDUS) will be the talk of the stock market on Friday as the stock will turn ex-dividend. The company's next dividend payment will be $0.52 per share, and in the last 12 months, it paid a total of $1.71 per share. Last year's total dividend payments show that FDUS has a trailing yield of 9.40% on the current share price of $18.16.
Global Indemnity Group LLC (GBLI) is also set to go ex-dividend tomorrow. The next dividend payment from GBLI will amount to $0.35 per share. March 20 has been designated as the record date for this dividend, with the actual payout scheduled for March 30. In the previous year, GBLI distributed a total of $1.40 to its valued shareholders. Considering the cumulative dividend payments from last year, the trailing yield for GBLI stands at 4.77% based on the current stock price of $29.35.
Hackett Group Inc (HCKT) will be paying out a dividend of $0.12 per share to shareholders holding their shares as of the close of business hours on the record date of March 20. Over the past 12 months, HCKT has paid out a total of $0.48 per share in dividends. Based on the total dividends paid out last year, HCKT boasts an impressive trailing yield of 3.67% on the current share price of $13.07.
This company is preparing for a Nasdaq listing - but by the time the bell rings, it may be too late. Already generating $6.4M in revenue, its Nature-Cide line is sold e-commerce giants like Amazon, Walmart, and Kroger and is expanding into 41+ markets.
As regulators, consumers, and climate pressure push the $17B pest control industry natural, this company is positioned to lead. Right now, shares are just $4.00 through a limited Reg A+ offering.
Don't wait for Wall Street's headlines-[review the opportunity now].
Disclosures: This is a paid advertisement for Med-X's Regulation A+ Offering. Please read the offering circular at invest.medx-rx.com.
Top performance-driven ad channel in 2026

"Did this campaign drive that sale, or would it have happened anyway?"
Every marketer asks it. Attribution can't answer it. Incrementality can.
CTV now brings that reporting rigor to television:
β
Smarter targeting
β
Proof of incremental lift
β
Ongoing optimization
Worth a look if you're spending on TV and need to prove it's worth it.
Sponsored
Crypto Market Highlights
Security researchers warned that a Coinbase Commerce-related page appeared to request usersβ wallet recovery phrases, raising concerns it could normalize phishing-style behavior.
OP_NET announced plans to launch a βSlowFiβ DeFi stack on Bitcoin using standard Bitcoin transactions and native BTC fees, avoiding bridges, wrapped assets, and separate gas tokens.
Apex Groupβs Tokeny partnered with Polygon Labs to introduce T-REX Ledger, a compliance-focused blockchain enabling regulated tokenized assets to move across networks without repeating investor checks.
Crypto.com plans to cut up to 12% of its workforce as part of company-wide AI integration efforts, CEO Kris Marszalek confirmed.
The European Central Bank is inviting industry experts to help design how the digital euro would operate across ATMs, payment terminals, and broader payment infrastructure.
Most Shorted Stocks
Intuitive Machines Inc (LUNR) was one of the most shorted stocks as of latest short interest figures, with 27.89% short interest. The days to cover ratio, a measure of how long it would take for all the short positions to be covered based on average trading volume, is 3.4. This represents a change of 2732999 shares, which corresponds to a 9.92% increase in short interest. The total value of the shares held short is estimated to be around $524.24 million. The average daily volume stands at 11.78M shares, and the market capitalization of the company is $3.52B.
For the stock Par Technology Corp (PAR), the current short interest is at 22.23%. This represents a significant short interest change of -336465 shares, corresponding to a short interest percentage decrease of -3.68%. The days needed to cover the short positions amount to 5.5. The approximate worth of the shares held short is $124.22 million.
With the symbol BOXL, the stock currently has a short interest of 22.47%. The short interest change is 67360 shares, compared with a short interest percentage change of 50.62%. It would take approximately 0.0 days to cover all the short positions. The shares' short value is estimated to be around $9.6 million. The company boasts an average daily volume of 6.85M shares, contributing to a market capitalization of $1.04M.
The stock SPCE has a current short interest of 21.15%. The short interest percentage has experienced a decrease of -9.55% while there was a change of -1626275 shares in short interest. The ratio indicating the time required to cover short positions is 9.4. The calculated worth of the shorted shares amounts to around $0.5 million. Trading activity averages at 3.52M shares per day, while the company's market capitalization stands at $182.45M.
Biotech Stocks to Watch
According to our ST Score evaluation, Context Therapeutics Inc (CNTX) emerges as a high-quality stock in the Biotech industry, attaining an impressive score of 54. The stock's performance and financial strength are strong. However, its growth and Piotroski Score are weak. Additionally, it is neutral in terms of profitability, stock sentiment, and forecast.
Our ST Score also classifies Crescent Biopharma Inc (CBIO) as a high-quality Biotech stock today, presenting a Score of 53. The stock has strong fundamentals in terms of performance, financial strength, and Piotroski Score. However, it has weak profitability, stock sentiment, and a forecast. The growth is neutral.
Another stock in the category, Day One Biopharmaceuticals Inc (DAWN) has the ST Score of 53, which means that the stock carries the potential for higher returns. The stock is strong in performance and financial strength. Profitability, growth, stock sentiment, Piotroski score, and forecast suggest a neutral outlook.
SAB Biotherapeutics Inc (SABS) stock has the ST Score of 54, which implies that the Biotech company has a high probability of beating the market. The stock's strengths lie in its profitability, performance, and financial strength, but its weaknesses lie in its growth. However, it shows a neutral outlook in stock sentiment, Piotroski Score, and forecast.
Enliven Therapeutics Inc (ELVN) currently has the ST Score of 53, which signifies a huge upward potential. The Biotech stock's strong points are its performance and financial strength, while its weak points are its growth and Piotroski Score. The stock's profitability, stock sentiment, and forecast indicate a neutral outlook.
That's it for today. Thanks for reading. Good luck out there!
π’ What do you think of our new Midday newsletter? |
Best Regards,
Stocks Telegraph Team
P.S. Want my daily watchlists sent to your cell phone too? Join our WhatsApp Exclusive Community for real-time alerts on hot stocks. Stay ahead with instant updates and exclusive insights!